Levothyroxine Recall: Levoxyl 175 mcg 1000-count bottle
Announced 2026-10-28 · FDA
Pfizer Levoxyl levothyroxine tablets, 175 mcg, 1000-count Rx bottles, distributed nationwide in the US and Puerto Rico, are recalled due to subpotent drug detected in stability testing (out-of-specification assay). The recall is Lot # 24W07, exp 11/30/2026. Corrective action is not provided.
| Brand | Pfizer |
|---|---|
| Product | Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10 |
| Reason | Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing. |
| Severity | moderate |
| Units affected | 15815 |
| Distribution | US Nationwide and Puerto Rico |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check your Levoxyl bottle for Lot # 24W07 and expiration date 11/30/2026.
- Do not use any tablets from this affected lot.
- Contact Pfizer or your pharmacist for instructions on return or replacement.
- If you are taking this medication, talk to your healthcare provider about next steps.
How to identify the recalled item
| Lot / date codes | Lot # 24W07, Exp: 11/30/2026 |
|---|---|
| Lot / date codes | Lot # 24W06, Exp: 11/30/2026 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other levothyroxine recalls
- Levothyroxine Recall: Macleods 150 mcg Rx Only 1000-tablet bottle · 2026-04-01
- Levothyroxine Recall: Thyro-Tabs 150mcg · 2026-01-21
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.